Holly Bradford
Clinical Trials Administrator
Holly joined the CTSU in August 2023 working on the ORION-4 study, a double-blind randomised placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic CVD.
Prior to this Holly worked as a Data Manager for the Cancer Research Clinical Trials Unit at the University of Birmingham on two phase III breast cancer studies. Holly completed her BSc in Biomedical Science from the University of Birmingham in July 2022, specialising in cancer sciences.